Increased conceptual switching by dopaminergic treatment in patients with Parkinson's disease

被引:5
|
作者
Tiedt, Hannes O. [1 ]
Ehlen, Felicitas [1 ,2 ]
Klostermann, Fabian [1 ,3 ]
机构
[1] Charite Univ Med Berlin, Dept Neurol, Motor & Cognit Grp, Campus Benjamin Franklin CBF, Hindenburgdamm 30, D-12203 Berlin, Germany
[2] Jud Krankenhaus Berlin, Dept Psychiat, Heinz Galinski Str 1, D-13347 Berlin, Germany
[3] Humboldt Univ, Berlin Sch Mind & Brain, Unter Linden 6, D-10099 Berlin, Germany
关键词
Parkinson's disease; Verbal fluency; Dopamine; Switches; Cluster; Semantic spreading activation; SPREADING-ACTIVATION THEORY; DEEP BRAIN-STIMULATION; VERBAL FLUENCY; WORKING-MEMORY; COGNITIVE PERFORMANCE; SEMANTIC ACTIVATION; DECISION-MAKING; MODULATION; LEVODOPA; OSCILLATIONS;
D O I
10.1016/j.bandc.2020.105611
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cognitive changes including reduced word production in verbal fluency (VF) tasks are frequently observed in Parkinson's disease (PD) with ambiguous effects of dopaminergic medication on these symptoms. Here, we studied the impact of dopaminergic medication on specific cognitive components underlying VF task performance in 21 participants with PD on their regular medication and following dopamine withdrawal compared with healthy controls. We used temporal cluster analysis (TCA) to differentiate phases of VF output relating to fast automatic lexical activation ('clusters') and slower attention-demanding shifts ('switches'). Dopaminergic medication led to increased switching and, in non-alternating VF tasks, to the formation of smaller and shorter word clusters. The number of switches was correlated with higher cognitive scores and showed an inverse relationship with VF error rates. Increased switching operations during VF task performance can be interpreted in view of nigrostriatal dopaminergic roles for balancing system state versus change propensities. The additional effect on word clustering suggests a modulation of semantic spreading activation mechanisms underlying lexical search, presumably involving non-nigrostriatal, e.g., mesocortical dopaminergic networks.
引用
下载
收藏
页数:8
相关论文
共 50 条
  • [21] Diplopia in Parkinson's disease, a possible role of dopaminergic treatment
    Belli, E.
    Del Prete, E.
    Frosini, D.
    Bonuccelli, U.
    Ceravolo, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 638 - 638
  • [22] Recent advances in dopaminergic strategies for the treatment of Parkinson's disease
    Mao, Qi
    Qin, Wang-zhi
    Zhang, Ao
    Ye, Na
    ACTA PHARMACOLOGICA SINICA, 2020, 41 (04): : 471 - 482
  • [23] Effects of dopaminergic treatment on bladder function in Parkinson's disease
    Winge, K
    Werdelin, LM
    Nielsen, KK
    Stimpel, H
    NEUROUROLOGY AND URODYNAMICS, 2004, 23 (07) : 689 - 696
  • [24] The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease
    Chase, TN
    DRUGS, 1998, 55 (Suppl 1) : 1 - 9
  • [25] Switching between abstract rules reflects disease severity but not dopaminergic status in Parkinson's disease
    Kehagia, Angie A.
    Cools, Roshan
    Barker, Roger A.
    Robbins, Trevor W.
    NEUROPSYCHOLOGIA, 2009, 47 (04) : 1117 - 1127
  • [26] Dopaminergic modulation of cortical function in patients with Parkinson's disease
    Mattay, VS
    Tessitore, A
    Callicott, JH
    Bertolino, A
    Goldberg, TE
    Chase, TN
    Hyde, TM
    Weinberger, DR
    ANNALS OF NEUROLOGY, 2002, 51 (02) : 156 - 164
  • [27] Dopaminergic influences on risk preferences of Parkinson’s disease patients
    Shunsuke Kobayashi
    Kohei Asano
    Nozomu Matsuda
    Yoshikazu Ugawa
    Cognitive, Affective, & Behavioral Neuroscience, 2019, 19 : 88 - 97
  • [28] Dopaminergic influences on risk preferences of Parkinson's disease patients
    Kobayashi, Shunsuke
    Asano, Kohei
    Matsuda, Nozomu
    Ugawa, Yoshikazu
    COGNITIVE AFFECTIVE & BEHAVIORAL NEUROSCIENCE, 2019, 19 (01) : 88 - 97
  • [29] Dopaminergic effects on cognitive performance in patients with Parkinson's disease
    Lange, KW
    Paul, GM
    Naumann, M
    Gsell, W
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1995, (46): : 423 - 432
  • [30] DOPAMINERGIC MODULATION OF WORKING MEMORY IN PARKINSON'S DISEASE PATIENTS
    Poston, Kathleen
    Tayim, Fadi
    YorkWilliams, Sophie
    Lambert, Jennie
    Menon, Vinod
    JOURNAL OF COGNITIVE NEUROSCIENCE, 2013, : 192 - 192